HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients.

Abstract
The authors conducted an open study of levetiracetam as add-on therapy in nine patients with well-defined progressive myoclonic epilepsies and refractory myoclonus. Myoclonus was evaluated semiquantitatively (territory, intensity, daily living activities). Five patients had improvement of their myoclonus score. Levetiracetam may benefit myoclonus in progressive myoclonic epilepsy.
AuthorsC Crest, S Dupont, E Leguern, C Adam, M Baulac
JournalNeurology (Neurology) Vol. 62 Issue 4 Pg. 640-3 (Feb 24 2004) ISSN: 1526-632X [Electronic] United States
PMID14981187 (Publication Type: Journal Article)
Chemical References
  • Anticonvulsants
  • Levetiracetam
  • Piracetam
Topics
  • Activities of Daily Living
  • Adolescent
  • Anticonvulsants (administration & dosage, therapeutic use)
  • Child
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • Humans
  • Levetiracetam
  • MERRF Syndrome (drug therapy)
  • Male
  • Piracetam (administration & dosage, analogs & derivatives, therapeutic use)
  • Treatment Outcome
  • Unverricht-Lundborg Syndrome (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: